Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Amgen Inc (AMGN)

Amgen Inc (AMGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 179,330,224
  • Shares Outstanding, K 536,435
  • Annual Sales, $ 28,190 M
  • Annual Income, $ 6,717 M
  • 60-Month Beta 0.58
  • Price/Sales 6.39
  • Price/Cash Flow 12.64
  • Price/Book 35.60
Trade AMGN with:

Options Overview Details

View History
  • Implied Volatility 31.08% ( -0.13%)
  • Historical Volatility 16.77%
  • IV Percentile 96%
  • IV Rank 87.92%
  • IV High 33.07% on 04/16/24
  • IV Low 16.53% on 09/01/23
  • Put/Call Vol Ratio 0.44
  • Today's Volume 8,988
  • Volume Avg (30-Day) 9,743
  • Put/Call OI Ratio 0.94
  • Today's Open Interest 180,092
  • Open Int (30-Day) 174,360

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 25 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 4.92
  • Number of Estimates 12
  • High Estimate 5.10
  • Low Estimate 4.78
  • Prior Year 5.00
  • Growth Rate Est. (year over year) -1.60%

Price Performance

See More
Period Period Low Period High Performance
1-Month
306.11 +9.39%
on 07/03/24
346.85 -3.46%
on 07/25/24
+22.03 (+7.04%)
since 06/26/24
3-Month
268.99 +24.48%
on 04/29/24
346.85 -3.46%
on 07/25/24
+64.87 (+24.03%)
since 04/26/24
52-Week
228.21 +46.73%
on 08/03/23
346.85 -3.46%
on 07/25/24
+99.64 (+42.36%)
since 07/26/23

Most Recent Stories

More News
10 Best Dividend Growth Stocks to Buy and Hold Forever

Discover 10 dividend growth powerhouses that could turbocharge your portfolio's long-term performance.

LOW : 238.87 (+1.75%)
V : 259.46 (+2.25%)
PH : 554.61 (+1.74%)
NDSN : 245.95 (+2.24%)
ABT : 105.24 (-0.68%)
TGT : 149.00 (+1.85%)
NKE : 72.56 (+1.61%)
SPGI : 489.82 (+1.34%)
AMGN : 334.85 (+0.16%)
ABBV : 185.16 (+1.64%)
What Is the Dividend Payout for Amgen Stock?

Amgen offers a packed pipeline and healthy dividend distributions.

AMGN : 334.85 (+0.16%)
Stock-Split Watch: 2 Healthcare Stocks That Look Ready to Split

Revenue is climbing at these two drug companies -- and the trend should continue.

WMT : 69.78 (-0.34%)
CMG : 49.83 (-1.95%)
NVO : 126.73 (-0.88%)
NVDA : 113.06 (+0.69%)
REGN : 1,078.63 (+1.36%)
BIIB : 211.17 (-7.15%)
AMGN : 334.85 (+0.16%)
LLY : 804.62 (-2.02%)
VRTX : 495.26 (+0.61%)
3 Dividend Growth Stocks to Buy and Hold

What's better than a dividend? A dividend that's growing.

ABBV : 185.16 (+1.64%)
AMGN : 334.85 (+0.16%)
GILD : 77.01 (+0.65%)
Eli Lilly Rose More Than 50% So Far This Year. Can It Soar Past $1,000 in the 2nd Half?

This pharma company is posting double-digit revenue growth.

GS : 499.03 (+1.49%)
NVO : 126.73 (-0.88%)
AMGN : 334.85 (+0.16%)
VKTX : 65.98 (+2.01%)
LLY : 804.62 (-2.02%)
Forget Eli Lilly: 3 Biotech Stocks to Buy Instead

Eli Lilly is a good stock to buy, but these should be even better.

LLY : 804.62 (-2.02%)
AMGN : 334.85 (+0.16%)
VRTX : 495.26 (+0.61%)
VKTX : 65.98 (+2.01%)
1 Dividend Growth Stock to Buy and Hold for 10 Years

This company's payouts look safe.

AMGN : 334.85 (+0.16%)
Can Amgen Stock Keep Trouncing the S&P 500?

Amgen's market-beating ways are unlikely to evaporate any time soon.

AMGN : 334.85 (+0.16%)
Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7.5 Billion by 2033

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:KYMR),(NASDAQ:GILD),(OTCQX:RHHBY),(NASDAQ:AMGN) EQNX::TICKER_END

ONCY : 1.0400 (unch)
ONC.TO : 1.44 (+1.41%)
KYMR : 44.54 (+1.14%)
RHHBY : 40.7600 (+3.03%)
GILD : 77.01 (+0.65%)
AMGN : 334.85 (+0.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two...

See More

Key Turning Points

3rd Resistance Point 343.76
2nd Resistance Point 341.35
1st Resistance Point 338.10
Last Price 334.85
1st Support Level 332.44
2nd Support Level 330.03
3rd Support Level 326.78

See More

52-Week High 346.85
Last Price 334.85
Fibonacci 61.8% 301.53
Fibonacci 50% 287.53
Fibonacci 38.2% 273.53
52-Week Low 228.21

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar